Got Inflammation? How LDN can help in the times of Covid-19.

Rhyena Halpern
20 May 2020
https://rhyhalpern.medium.com/got-inflammation-how-ldn-can-help-in-the-times-of-covid-ac9694ad1b29

Covid-19 Long Haulers

Pensum Regenerative Medicine
09 February 2021
https://www.pensummed.pro/blogs/covid-19-long-haulers

Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19

ClinicalTrial.gov
28 April 2020
https://clinicaltrials.gov/ct2/show/NCT04365985

Phase 2 Trial to Evaluate Safety and Efficacy of CYTO-205 in Mild COVID-19

ClinicalTrials.gov
13 January 2021
https://www.clinicaltrials.gov/ct2/show/NCT04708327?term=Cytocom&draw=2&rank=1

Medicine specialist talks treatments for lingering COVID-19 symptoms

WWBT
03 March 2021
https://www.nbc12.com/2021/03/04/medicine-specialist-talks-treatments-lingering-covid-symptoms/

What COVID-19 Teaches Us About Rare Diseases

Pain News Network
27 February 2021
https://www.painnewsnetwork.org/stories/2021/2/26/what-covid-19-teaches-us-about-rare-diseases

SINK COVID-19 study: Can common drugs offer 2-step approach to combat deadly virus?

Beaumont News Releases
04 May 2020
https://www.beaumont.org/health-wellness/press-releases/sink-covid-19-study-can-common-drugs-offer-2-step-approach-to-combat-deadly-virus

Impact of Colchicine and Low-dose Naltrexone on COVID-19 (COLTREXONE)

HealthPartners institute
16 February 2021
https://clinicaltrials.gov/ct2/show/NCT04756128

Scientists Think They've Figured Out What's Triggering Brain Fog in COVID-19 Patients

MSN News Science Alert
11 February 2021
https://www.msn.com/en-us/news/technology/scientists-think-theyve-figured-out-whats-triggering-brain-fog-in-covid-19-patients/ar-BB1dBTTF?li=BBnbfcL

Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients

Cancer Cell
16 January 2021
https://www.cell.com/cancer-cell/fulltext/S1535-6108(21)00051-9